Abstract

Background. Syphilis is curable but Herpes Simplex Virus-2 (HSV-2) is not. As a result, the prevalence of syphilis but not HSV-2 may be influenced by the efficacy of national STI screening and treatment capacity. If the prevalence of syphilis and HSV-2 is found to be correlated, then this makes it more likely that something other than differential STI treatment is responsible for variations in the prevalence of both HSV-2 and syphilis. Methods. Simple linear regression was used to evaluate the relationship between national antenatal syphilis prevalence and HSV-2 prevalence in women in two time periods: 1990–1999 and 2008. Adjustments were performed for the laboratory syphilis testing algorithm used and the prevalence of circumcision. Results. The prevalence of syphilis was positively correlated with that of HSV-2 for both time periods (adjusted correlations, 20–24-year-olds: 1990–99: R 2 = 0.54, P < 0.001; 2008: R 2 = 0.41, P < 0.001 and 40–44-year-olds: 1990–99: R 2 = 0.42, P < 0.001; 2008: R 2 = 0.49, P < 0.001). Conclusion. The prevalence of syphilis and HSV-2 is positively correlated. This could be due to a common set of risk factors underpinning both STIs.

Highlights

  • Is there a correlation between the national prevalence of syphilis and Herpes Simplex Virus-2 (HSV-2)? The answer to this question may provide useful information on the determinants of differences in STI prevalence

  • It has long been argued that STI screening and treatment efficacy (STISTE) was instrumental in the large reductions in syphilis prevalence seen in the mid-20th century in many countries [1]

  • We found a positive association between syphilis prevalence and 20–24-year-olds HSV-2 prevalence (1990–99: R2 = 0.59, P < 0.001, n = 32; 2008: R2 = 0.41, P < 0.001, n = 31; Figure 2) and 40–44-year-olds HSV2 prevalence (1990–99: R2 = 0.41, P < 0.001, n = 26; 2008: R2 = 0.49, P < 0.001, n = 36)

Read more

Summary

Introduction

Is there a correlation between the national prevalence of syphilis and Herpes Simplex Virus-2 (HSV-2)? The answer to this question may provide useful information on the determinants of differences in STI prevalence. The prevalence of HSV-2 can be thought of as a measure of the prevalence of non-STI-STE related risk factors in a population [6]. It is more useful in this regard than HIV as, unlike HIV, HSV-2’s transmission/acquisition has not been shown to be enhanced by the presence of other STIs such as syphilis [7, 8]. If we find a correlation this makes it more probable that shared risk factors are responsible and that STI-STE is less likely to be a major player in this regard. This could be due to a common set of risk factors underpinning both STIs

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call